Fatemeh Aghamahdi
Overview
Explore the profile of Fatemeh Aghamahdi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noorian S, Soltani H, Aghamahdi F, Savad S, Alan M
Clin Case Rep
. 2025 Feb;
13(2):e70234.
PMID: 39980897
Isolated growth hormone deficiency (IGHD) IA is inherited autosomal recessively and occurs due to GH1 gene deletions. This study emphasizes the importance of clinical diagnosis and molecular examination for detecting...
2.
Savad S, Modarressi M, Younesi S, Seifi-Alan M, Samadaian N, Masoomy M, et al.
Neuromolecular Med
. 2024 Jul;
26(1):28.
PMID: 38954284
Neurofibromatosis type 1 (NF1) is a genetic disorder caused by mutations in the NF1 gene. This disorder shows nearly complete penetrance and high phenotypic variability. We used the whole-exome sequencing...
3.
Fayyaz F, Mardi P, Sobhani S, Sokoty L, Aghamahdi F, Qorbani M
J Diabetes Metab Disord
. 2024 Jun;
23(1):783-788.
PMID: 38932841
Background And Objectives: Psychological factors and patients' health-related quality of life (HRQOL) affect the outcome of patients with type 1 diabetes mellitus (T1DM). In this study, we aimed to determine...
4.
Heidari E, Shafiee A, Noorian S, Rafiei M, Abbasi M, Amini M, et al.
Diabetes Metab Res Rev
. 2024 May;
40(4):e3806.
PMID: 38757421
Background: The management of Type 1 Diabetes Mellitus (T1DM) is a significant clinical challenge. This study evaluated the efficacy of teplizumab, an immunomodulatory drug, in patients with T1DM, using a...
5.
Mahdavi F, Tavakol M, Aghamahdi F, Sadri H, Chavoshzadeh Z, Jamee M, et al.
Endocr Metab Immune Disord Drug Targets
. 2023 Sep;
24(7):798-807.
PMID: 37702233
Background: Autoimmunity can be the first or predominant manifestation in patients with primary immunodeficiency disorder, also known as inborn errors of immunity (IEI). This study aims to evaluate the immune...
6.
Sharifinejad N, Azizi G, Chavoshzadeh Z, Mahdaviani S, Alan M, Tavakol M, et al.
Front Immunol
. 2022 Dec;
13:1023127.
PMID: 36544766
Background: Combined immune deficiencies (CIDs) with associated or syndromic features are a highly heterogeneous subgroup of inherited immune disorders. These patients represent specific clinical complications with an increased risk of...
7.
Association of cardiometabolic risk factors with insulin resistance in overweight and obese children
Daneshzad E, Rostami S, Aghamahdi F, Mahdavi-Gorabi A, Qorbani M
BMC Endocr Disord
. 2022 Dec;
22(1):320.
PMID: 36529727
Introduction: Regarding the increased prevalence of obesity among children and adolescents, and the impact of obesity on insulin resistance (IR) and other metabolic disorders, this study was performed to determine...
8.
Fayyaz F, Aghamahdi F, Noorian S, Tabatabaei-Malazy O, Qorbani M
J Diabetes Metab Disord
. 2022 Sep;
21(2):1591-1597.
PMID: 36065331
Purpose: Type 1 diabetes mellitus (T1DM) is a chronic metabolic disorder, and its prevalence and incidence are increasing globally. Insulin therapy is the basis of T1DM management that can prevent...
9.
Aghamahdi F, Nirouei M, Savad S
J Med Case Rep
. 2022 Jul;
16(1):288.
PMID: 35883096
Background: Niemann-Pick type A (NP-A) is a congenital, hereditary disease caused by a deficiency in acid sphingomyelinase, a lysosomal enzyme. This deficiency results in an accumulation of sphingomyelin in lysosomes,...
10.
Aghamahdi F, Shafiee A, Rostami S, Mokhames Z, Safavi M, Yaslianifard S, et al.
Diabetes Metab Syndr
. 2022 May;
16(5):102499.
PMID: 35580523
Background And Aims: The COVID-19 pandemic has prompted researchers to look for effective therapeutic targets. The effect of endocannabinoid system against infectious diseases is investigated for several years. In this...